Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000950157-02-000804
Filing Date
2002-11-22
Accepted
2002-11-22 16:51:40
Documents
2
Effectiveness Date
2002-11-22

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A dfan14a.txt DFAN14A 13030
3 TELECONFERENCE TRANSCRIPT ex99-1.txt EX-99.1 20578
  Complete submission text file 0000950157-02-000804.txt   35616
Mailing Address
Business Address 215 COLLEGE RD PARAMUS NJ 07652 2012611331
SYNAPTIC PHARMACEUTICAL CORP (Subject) CIK: 0000884939 (see all company filings)

EIN.: 222859704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-27324 | Film No.: 02838225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9 OTTILIAVEJ DK 2500 VALBY COPENHAGEN DENMARK G7 00000
Business Address 9 OTTILIAVEJ DK 2500 VALBY COPENHAGEN DENMARK G7 00000 4526301311
H LUNDBECK A S (Filed by) CIK: 0001206828 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231